Radical prostatectomy for low-risk prostate cancer following initial active surveillance: Results from a prospective observational study

European Urology

Volumn 62, Issue 2, 2012, Pages 195-200

  Bul, Meelan ^a   Zhu, Xiaoye ^a   Rannikko, Antti ^b   Staerman, Frédéric ^c   Valdagni, Riccardo ^d   Pickles, Tom ^e   Bangma, Chris H ^a   Roobol, Monique J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Polyclinique les Bleuets ^*  (France)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Active surveillance; Disease progression; Prostatic neoplasms; Radical prostatectomy; Reclassification; Risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANXIETY; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; STATISTICS;

EID: 84862869430     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.02.002     Document Type: Article

References (30)

1. R.C. van den Bergh, H. Vasarainen, and H.G. van der Poel Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study BJU Int 105 2010 956 962
2. L. Klotz Active surveillance with selective delayed intervention for favorable risk prostate cancer Urol Oncol 24 2006 46 50 (Pubitemid 43097357)
3. H.B. Carter, P.C. Walsh, P. Landis, and J.I. Epstein Expectant management of nonpalpable prostate cancer with curative intent: preliminary results J Urol 167 2002 1231 1234 (Pubitemid 34132060)
4. C. Parker Active surveillance: towards a new paradigm in the management of early prostate cancer Lancet Oncol 5 2004 101 106 (Pubitemid 38145893)
5. M.S. Soloway, C.T. Soloway, S. Williams, R. Ayyathurai, B. Kava, and M. Manoharan Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience BJU Int 101 2008 165 169 (Pubitemid 350294039)
6. M.A. Dall'Era, B.R. Konety, and J.E. Cowan Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664 2670 (Pubitemid 351969209)
7. T.J. Daskivich, K. Chamie, and L. Kwan Comorbidity and competing risks for mortality in men with prostate cancer Cancer 117 2011 4642 4650
8. Prostate Cancer Research International: Active Surveillance. Active surveillance of early prostate cancer. PRIAS Web site. http://www.prias-project. org. Accessed November 14, 2011.
9. O. Alenda, G. Ploussard, and P. Mouracade Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors World J Urol 29 2011 671 676
10. M.R. Cooperberg, J.E. Cowan, and J.F. Hilton Outcomes of active surveillance for men with intermediate-risk prostate cancer J Clin Oncol 29 2011 228 234
11. Isharwal S, Makarov DV, Sokoll LJ, et al. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program. Urology 2011;77:763 e1-6.
12. M.A. Dall'Era, J.E. Cowan, and J. Simko Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment BJU Int 107 2011 1232 1237
13. R.C. van den Bergh, E.W. Steyerberg, and A. Khatami Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281 1290
14. C. Warlick, B.J. Trock, P. Landis, J.I. Epstein, and H.B. Carter Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355 357 (Pubitemid 43338215)
15. B. Holmstrom, E. Holmberg, and L. Egevad Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study J Urol 184 2010 1322 1327
16. A.J. Vickers, F.J. Bianco Jr., S. Boorjian, P.T. Scardino, and J.A. Eastham Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? Cancer 106 2006 576 580 (Pubitemid 43157620)
17. S.A. Boorjian, F.J. Bianco Jr., P.T. Scardino, and J.A. Eastham Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? BJU Int 96 2005 773 776 (Pubitemid 41391377)
18. W.V. Shappley III, S.A. Kenfield, and J.L. Kasperzyk Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort J Clin Oncol 27 2009 4980 4985
19. D. O'Brien, S. Loeb, and G.F. Carvalhal Delay of surgery in men with low risk prostate cancer J Urol 185 2011 2143 2147
20. S.J. Freedland, C.J. Kane, and C.L. Amling Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer J Urol 175 2006 1298 1302 discussion 1302-3
21. J.A. Lane, F.C. Hamdy, R.M. Martin, E.L. Turner, D.E. Neal, and J.L. Donovan Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies Eur J Cancer 46 2010 3095 3101
22. S.L. Conti, M. Dall'era, V. Fradet, J.E. Cowan, J. Simko, and P.R. Carroll Pathological outcomes of candidates for active surveillance of prostate cancer J Urol 181 2009 1628 1633 discussion 1633-4
23. Drouin SJ, Comperat E, Cussenot O, Bitker MO, Haertig A, Roupret M. Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy. Urol Oncol. In press. doi:10.1016/j.urolonc.2010.04.004.
24. C.S. Thaxton, S. Loeb, K.A. Roehl, D. Kan, and W.J. Catalona Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols Urology 75 2010 414 418
25. C.J. Kane, R. Im, and C.L. Amling Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database Urology 76 2010 695 700
26. G.S. Kulkarni, G. Lockwood, and A. Evans Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy Cancer 109 2007 2432 2438 (Pubitemid 46906461)
27. A. Khatami, G. Aus, J.E. Damber, H. Lilja, P. Lodding, and J. Hugosson PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section Int J Cancer 120 2007 170 174
28. Seiler D, Randazzo M, Klotz L, et al. Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort. BJU Int. In press. doi:10.1111/j.1464-410X.2011.10707.x.
29. J.I. Epstein, P.C. Walsh, M. Carmichael, and C.B. Brendler Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368 374 (Pubitemid 24037911)
30. A.S. Duffield, T.K. Lee, H. Miyamoto, H.B. Carter, and J.I. Epstein Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails J Urol 182 2009 2274 2278